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Graded Decompression of Orbital Fat and Wall in Patients with 
Graves’ Orbitopathy
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1Department of Ophthalmology, Institute of Vision Research, Yonsei University College of Medicine, Seoul, Korea
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Purpose: To investigate the results of graded decompression of orbital fat and walls in Graves’ orbitopathy 
(GO) considering the degree of proptosis reduction at surgery and preoperative computed tomography (CT) 
findings. 
Methods: This is a retrospective interventional case series. Graded orbital fat and wall decompression was per-
formed in 90 orbits of 55 patients. In patients with enlarged extraocular muscles and minimal orbital fat prolifer-
ation in preoperative CT scans, one- or two-wall decompression of posterior orbit was performed with minimal 
fat excision. In other cases, the maximal amount of fat tissue was removed from the post-septal area to the 
apex. If the proptosis was not satisfactorily symmetrically reduced at surgery, one- or two-wall decompression 
was performed successively. Symmetric reduction of proptosis was consistently confirmed intraoperatively to 
assure that a desired amount of exophthalmos reduction was achieved. 
Results: Four types of decompression were performed: fat only (group 1), fat and one-wall (group 2), fat and 
two-wall (group 3), and two-wall and minimal fat decompression (group 4). The mean preoperative Hertel 
value (20.6 ± 2.8 mm) was reduced significantly at six months postoperatively (16.1 ± 2.3 mm). Proptosis sig-
nificantly decreased with a mean of 4.3 ± 1.7 mm, and the reduction was greatest (5.1 ± 2.1 mm) in group 3. In 
group 1, a significant correlation between Hertel change and the volume of resected orbital fat was found (r = 
0.479). Diplopia was newly developed or aggravated postoperatively in eight patients, and six of these patients 
were in group 3. With the exception of one patient, visual acuity improved to nearly normal postoperatively in 
all patients with optic neuropathy. 
Conclusions: Graded orbital decompression of orbital fat and bony walls, as assessed by the degree of pro-
ptosis reduction during surgery, was effective and predictable with minimal complications in GO patients with 
vision-threatening or cosmetically disfiguring proptosis.
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Graves’ disease is an autoimmune disease of the thyroid 
gland that activates gland function, leading to excessive pro-
duction of thyroid hormones. Up to 50% of patients with 
Graves’ disease present with pathological features in the 
eye, known as Graves’ orbitopathy (GO) [1-3]. The most 
common manifestations of GO include upper eyelid retrac-
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tion, edema, erythema of periorbital tissues, and proptosis. 
Approximately 3% to 5% of individuals with GO suffer 
from intense pain and inf lammation, diplopia, and vi-
sion-threatening compressive optic neuropathy.
The well-established treatments for GO are systemic im-
munosuppression with glucocorticoids, external beam ra-
diotherapy, and surgery, including orbital decompression 
and corrective surgery for eyelid retraction and restrictive 
myopathy [4]. Indications for orbital decompression in-
clude optic neuropathy, persistent inflammation or conges-
tion refractory to steroid treatment, and the desire to re-
duce excess proptosis. Recently, the indications for surgery 
have increased to include not only optic neuropathy or se-
vere proptosis causing exposure keratopathy, but also cos-
metic disfigurement [5]. As surgical indications expand, 
preoperative conditions have diversified, and there is a 
need to adjust surgical methods on an individual basis. 
Several types of orbital decompression have been de-
scribed, including combinations of lateral wall, medial 
wall, floor, and orbital fat decompression [6-8].
Several studies have investigated the effect of graded orbit-
al bony decompression through various approaches to achieve 
the desired effect in proptosis reduction with minimal in-
duced diplopia [5,9-13]. Orbital fat decompression techniques 
have been reported to offer significant reduction in proptosis 
in fat-predominant GO patients, with a low complication rate 
[14,15]. Kikkawa et al. [9] reported a graded orbital decom-
pression based on preoperative exophthalmos. Recently, bal-
anced medial and lateral wall decompression with or without 
orbital fat decompression has been reported to be effective in 
reducing proptosis, postoperative diplopia, and postoperative 
hypoglobus [11,16,17]. Surgeons must decide whether or how 
to remove orbital bony wall(s) and fat, as well as the amount 
and location of fat and/or bone removal.
In our experience, the amount of fat removed during sur-
gery or the reductive effect of removing the same amount of 
fat cannot be completely predicted by preoperative com-
puted tomography (CT) scans or exophthalmos alone but 
can be predicted according to the state of orbital adipose 
tissue fibers or the stiffness of extraocular muscles. Thus, 
the surgical method can be adapted intraoperatively ac-
cording to the degree of proptosis reduction and the degree 
of muscle enlargement on preoperative CT scan. The pur-
pose of this study was to investigate surgical outcomes of 
graded decompression of orbital fat and bony wall(s) by in-
traoperative evaluations of proptosis reduction.  
Materials and Methods
Patients
A consecutive group of patients undergoing orbital de-
compression for GO between January 2009 and June 2012 
was studied retrospectively. Data were obtained from the 
electronic medical records of Severance Hospital, Yonsei 
University College of Medicine, Seoul, Korea. All surgery 
was performed by one surgeon (JSY). Patients with at least 
six months of follow-up after surgery were recruited. The 
present retrospective study was approved by the Ethics 
Committee of Yonsei University College of Medicine, 
Seoul, Korea.
Preoperative examinations included complete ophthal-
mic evaluations with best-corrected visual acuity (BCVA), 
Hertel exophthalmometry (Carl Zeiss, Jena, Germany), in-
traocular pressure, HESS screening, and Goldmann binoc-
ular single vision (BSV) test to assess the range of extraoc-
ular muscle motility and diplopia. Preoperative orbital CT 
was obtained for all patients to evaluate the degree of ex-
traocular muscle or orbital fat enlargement and evidence of 
a crowding apex. Postoperative assessments were per-
formed one week and one, three, and six months after sur-
gery. Particular attention was paid to preoperative and 
postoperative Hertel values (six months after surgery). 
Myopathy scoring was obtained from all patients before 
and after surgery. All patients were scored from 3 to 0 (3 = 
primary diplopia or no orthotropia at the primary position, 
2 = orthotropia at the primary position, but with diplopia 
within 30° in BSV or more than 10° limitation in HESS, 1 = 
diplopia only outside 30° in BSV, 0 = no diplopia at any gaze). 
Indications for orbital decompression included compres-
sive optic neuropathy or persistent congestion refractory to 
steroid treatment and the desire to reduce excess proptosis 
for cosmetic improvement. In cases of cosmetically disfig-
uring proptosis, we preoperatively confirmed clinically 
metabolically inactive disease status of the patient for at 
least six months. 
Surgical technique
In patients presenting with enlargement of extraocular 
muscles and minimal to no orbital fat proliferation in pre-
operative CT scans, the posterior part of one wall (ethmoid 
bone) or two walls (ethmoid bone and orbital floor medial 
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to the infraorbital nerve complex involving the posterior 
strut) were removed with minimal fat excision (less than 1 
mL) (Fig. 1). However, in cases with fat volume enlarge-
ment shown in CT scans, decompression of fat alone or in 
combination with one or two bony walls, was accom-
plished through a combined canthofornix and caruncular 
approach according to the reduction of proptosis during 
surgery (Fig. 1). All patients with optic nerve compression 
required two-wall decompression, with or without fat re-
moval. 
Under general anesthesia, the operation was performed 
through a swinging eyelid approach. After incision, the or-
bital septum was visualized all the way caudal to the arcus 
marginalis. Intraoperative photographs of fat removal are 
shown in Fig. 2. All post-septal medial, central, and lateral 
fat pads were excised after septal incision. Extraconal adi-
pose tissues were carefully removed with cutting and cau-
tery. For further fat removal, intermuscular connective tis-
sues and muscle-periorbital septa were dissected. Since the 
inferotemporal pocket between the lateral and inferior rec-
tus muscles has the largest amount of fat and is relatively 
safe to dissect, fat was removed until the surfaces of the 
inferior oblique muscle and inferior rectus muscle were 
clearly visible and was further resected immediately prox-
imal to the anterior end of the inferior ophthalmic fissure 
(Fig. 2B and 2D). In the inferomedial space, the septa was 
incised to remove fat, but care was taken to avoid the in-
sertion site of the inferior oblique muscle (Fig. 2B and 2D), 
and the fat medial to the medial rectus muscle was re-
moved through a transcaruncular approach. Superomedial 
fat was additionally removed by incising the intermuscular 
septum above the medial rectus muscle. In this way, the 
maximum amount of orbital fat could be removed while 
sparing only the superotemporal fat around the lacrimal 
gland and superior fat tissues. For further decompression, 
the deep and posterior loose intraconal fat was carefully 
removed using forceps and scissors as necessary. The vol-
ume of removed fat was measured using a 10-mL syringe. 
During surgery, symmetric reduction of proptosis was 
intraoperatively confirmed by one surgeon. The height of 
the cornea apex was measured with a ruler from the level 
of the bony edge of the zygoma at the lateral canthus by 
looking parallel to the plane of the patient’s eye from the 
side. Symmetry was verified by looking down from the 
patient’s head with the eyes at the same level as the fron-
tal bone, to assure that the desired amount of exophthal-
mos reduction (mm) was achieved (Fig. 3A and 3B). If fat 
decompression alone was insufficient for proptosis reduc-
tion, a transcaruncular orbital decompression of the pos-
terior ethmoid bone was then performed (Fig. 3A and 
3B). If exophthalmos was still significant or not symmet-
rical, the posterior part of the orbital f loor was decom-
pressed, mostly involving the posterior strut, as shown in 
Fig. 3C and 3D. A Barovac (Cardinal Health, Dublin, OH, 
USA) drain was inserted through a stab skin incision at 
the inferior orbital rim to prevent postoperative retrobul-
bar bleeding. The conjunctiva was closed using 6-0 ab-
sorbable Vicryl sutures. Intravenous methylprednisolone 
(250 mg for one day) and oral prednisolone (20 mg daily 
for two weeks and then 15 mg daily for two weeks) were 
given postoperatively.
Statistical analyses
SPSS ver. 18.0 (SPSS Inc., Chicago, IL, USA) was used. 
Paired t-test, ANOVA with Bonferroni correction, and 
Pearson’s chi-squared test were used to compare demo-
Preoperative evaluation of CT scan
Muscle volume (+)
without fat proliferation
1-Wall (ethmoid) or 2-wall
(+ floor with posterior strut)
Fat proliferation (+)
with or without muscle enlargement
Fat removal (inferotemporal→medial)
Intraoperative assessment
of proptosis
1-Wall (ethmoid) or 2-wall
(+ floor with posterior strut)
Fig. 1. Algorithm of the surgical approach for orbital fat and/or 
bony decompression according to preoperative computed tomog-
raphy (CT) scans in patients with Graves’ orbitopathy. When pre-
operative CT scans showed significant extraocular muscle (EOM) 
enlargement with minimal fat proliferation, posterior one-wall 
(ethmoid) or two-wall (combined with orbital f loor, including 
the posterior strut) decompression was performed without fat re-
moval or with minimal fat removal (less than 1 mL). However, if 
increased orbital fat volume was primarily observed, rather than 
EOM enlargement shown in CT scans, the maximal amount of 
extraconal fat tissue was removed from the inferotemporal area, 
towards the medial orbit, with conservative removal of intraconal 
fat tissues. If proptosis was not sufficiently and symmetrically 
reduced during surgery, a one-wall or two-wall decompression 
was added successively until sufficient reduction of proptosis was 
achieved.
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graphics and postoperative outcomes between different 
surgical groups. Pearson correlation and linear regression 
analysis were performed to correlate the resected amount 
of fat and postoperative Hertel change. The results were 
considered statistically significant if p-value was less than 
0.05.
Fig. 2. Intraoperative photographs showing fat removal method. After removal of the post-septal medial, central, and lateral fat pads, maxi-
mal amounts of caruncular (A),  inferolateral and inferomedial fat tissues (B) were removed through transcaruncle and canthofornix incision 
after careful dissection of intermuscular septa without damaging the medial, inferior rectus muscle (IR) and inferior oblique (IO) muscle. 
(C,D) Fat was removed until the surface of the IO muscle, and inferior and medial rectus muscle (MR) were clearly visible, and was further 
resected immediately proximal to the anterior end of the inferior ophthalmic fissure. Superomedial fat was additionally removed by incising 
the intermuscular septum above the MR, and for further decompression, the deep and posterior loose intraconal fat was carefully removed 
until satisfactory reduction of proptosis was achieved using forceps and scissors conservatively. Severe exophthalmos (E) was significantly 
reduced (F) by the removal of orbital fat. The level of corneal apex became lower than the eyelids. *Deep posterior intraconal fat.
FE
A B
C D
IO
MR
IR
IO
*
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A
B
C
D
Fig. 3. Intraoperative photographs showing adjustment of the decompression method according to intraoperative assessment of proptosis 
reduction (A) By Hertel exophthalmometry, 22.5 and 24 mm of exophthalmos in the right and left eyes, respectively were measured be-
fore surgery. (B) After the removal of the maximal amount of fat (right, 4.8 mL OD; left, 3.8 mL OS) in both eyes, satisfactory reduction 
of proptosis was achieved in the right eye through fat-only decompression. However, a posterior two-wall decompression was further 
performed in the left eye to achieve a sufficient proptosis reduction. Finally, the level of cornea apex became lower as much as desired 
amount of decompression with symmetry. (C) Preoperative computed tomography (CT) scans (axial, coronal, and sagittal views) shows 
significant increases in fat volume without extraocular muscle involvement. (D) Postoperative CT scans (axial, coronal, and sagittal 
views) show significantly decreased volumes of extraconal and intraconal fat tissues, especially at the inferior orbit in both eyes.
OD: 22.5 mm
OD: 17 mm
OD
OD
OS: 24 mm
OS: 17.5 mm
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Results
In total, 55 patients (90 orbits) who underwent graded 
orbital decompression with at least six months of postoper-
ative follow-up were recruited. We grouped eyes according 
to the type of surgery performed and according to the 
amount of fat and the number of decompressed orbital 
bone(s) (Table 1). Fat-only decompression (group 1), fat and 
one-wall decompression (group 2), fat and two-wall de-
compression (group 3), and two-wall decompression with 
minimal fat (<1 mL) (group 4) was performed in 29 eyes 
(17 patients), 15 eyes (10 patients), 36 eyes (22 patients), and 
10 eyes (6 patients), respectively. Table 1 shows preopera-
tive demographic and clinical characteristics. 
In preoperative CT scans, ten eyes showed significant 
enlargement of extraocular muscles with minimal to no 
orbital fat proliferation. These cases presented with vi-
sion-threatening optic neuropathy with apical crowding as 
shown in CT scans (five eyes) or severe congestion refrac-
tory to steroid treatment (five eyes). In these cases, two-
wall decompression with posterior strut removal was per-
formed with minimal fat excision (group 4). 
In the other 80 eyes, a considerable amount of fat de-
compression, with or without bony wall removal, was per-
formed (groups 1 to 3). In 49 eyes (54%), there was fat vol-
ume enlargement without muscle involvement shown in 
preoperative CT scans (25 eyes in group 1 [86%], 15 eyes 
in group 2 [100%], and 13 eyes in group 3 [36%]). 
There were 14 eyes with compressive optic neuropathy. 
All underwent two-wall decompression with minimal (n = 
5, group 4) or significant (n = 9, group 3) removal of orbital 
fat tissues, as shown in Fig 4. With the exception of one 
patient who had preoperative visual acuity of hand motion 
in one eye due to prolonged compression, preoperative 
BCVA (all less than 40 / 200 on a Snellen chart with rela-
tive afferent pupillary defect [RAPD]) significantly im-
proved postoperatively to nearly normal vision without 
RAPD. 
The mean preoperative Hertel values (20.6 ± 2.8 mm) 
were significantly reduced at six months after surgery (16.1 
± 2.3 mm, p < 0.05) (Table 2). Mean preoperative exoph-
thalmos was greatest in group 3 (21.3 ± 3.6 mm, p = 0.04); 
however, no difference was found in postoperative Hertel 
values between groups (p = 0.832). Proptosis significantly 
decreased with a mean of 4.3 ± 1.7 mm, and the reduction 
was greatest (5.1 ± 2.1 mm, p = 0.002) in group 3. 
The mean amount of fat removed during surgery was 2.1 
± 0.9 mL in 80 eyes of groups 1 to 3 (Table 2). The amount 
of fat removed was greatest in group 1 (3.9 ± 1.0 mL; 
range, 2.5 to 6; p < 0.001), where we found a significant 
correlation between Hertel change and the volume of re-
sected orbital fat with a correlation coefficient of 0.479 (p 
= 0.009). Linear regression revealed the following equa-
tion: 0.481 × resected fat volume (mL) + 2.456. However, 
the average Hertel change versus resected orbital fat vol-
ume was approximately 1 (3.8 / 3.9). 
With respect to diplopia, seven patients reported diplopia 
at primary gaze, scoring 3 with significant restriction of 
motility both before as well as after surgery. In eight addi-
tional patients, six of whom were included in group 3, the 
myopathy score increased from 2 to 3 (Table 2). Twelve 
patients reported clinically insignificant diplopia outside 
30° in BSV after surgery, requiring no further surgical 
treatment. 
All patients exhibited insignificant hypoesthesia in the 
lower cheek area, but all resolved after six months postop-
eratively. Otherwise, no significant intraoperative or post-
operative complications developed.
Discussion 
GO can be categorized into fat-, muscle-, or inflammato-
ry-dominant, or more frequently, combined type. Many 
variations in orbital decompression have been introduced 
for treatment of this condition [7,18-21]. The amount of 
proptosis reduction has been reported to be associated with 
the number of walls removed [6], the number and size of 
cuts made in the periorbita [22], and the type of preopera-
tive proptosis [23]. However, because many complex fac-
tors influence the amount of proptosis reduction, it is diffi-
cult to predict postoperative outcomes of decompression 
[11,18,23-25]. To date, thyroid orbital surgeons have devel-
oped their own surgical procedures to best predict favor-
able surgical outcomes. In this study, we present our post-
operative results after combined graded fat and bony wall 
decompression, adjusted by intraoperative assessment of 
proptosis reduction. Symmetric reduction of proptosis and 
desired amount of decompression were consistently mea-
sured and confirmed by one surgeon during surgery. In 
our study, proptosis decreased to a mean of 4.3 ± 1.7 mm, 
and there was no significant difference in postoperative ex-
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ophthalmos between the groups, although preoperative ex-
ophthalmos differed in each group. A mean of 3.8 mm and 
5.1 mm of proptosis reduction was observed in patients who 
underwent fat only removal (3.9 ± 1.0 mL) and combined fat 
and two-wall decompression (2.3 ± 1.1 mL), respectively. 
As previous studies reported, GO has a complicated 
pathogenesis and differs in each case. There is no single, 
all-purpose method of treatment or evaluation [14,15,26-
28]. With repeated surgery, clinicians can develop their 
own standardized intraoperative evaluation methods. Pos-
terior medial and floor decompression surgery is a tradi-
tional technique. Using the results of preoperative CT 
analysis, we decided to perform two bony wall decompres-
sions in cases with predominantly muscle-enlarged orbits 
with minimal to no fat proliferation, and minimal to no fat 
(less than 1 mL) was removed, as anticipated. In cases with 
more than moderately enlarged fat tissues, prolapsing ex-
traconal and intraconal fat tissues were first removed, and 
conservative deep and posterior intraconal fat excision was 
performed with special care via the transcanthoforniceal 
and caruncle swinging eyelid approach. We cannot com-
pletely preoperatively predict the required amount of fat 
removal or the number and position of bone removal for 
sufficient proptosis removal based only on CT scan and 
exophthalmos since the characteristics of GO orbital tis-
sues are largely heterogeneous with respect to fibrotic na-
ture. The effect of decompression can be far weaker in pa-
tients with more fibrotic orbital tissues, which cannot be 
predicted before surgery. Therefore, by intraoperative eval-
uation of proptosis reduction, we successively performed 
bony wall decompression involving the posterior ethmoid, 
with or without the posteroinferior wall and posterior strut. 
This surgical step was quite effective for cosmetic improve-
ment and minimized new onset of diplopia after surgery. 
Proptosis reduction by fat removal is reported to range 
from 1.8 to 4.4 mm, which is comparable to bony decom-
pression [24,28-32]. After fat only removal in 29 eyes of 
our cases, a significant correlation was found between 
Hertel change and the volume of resected orbital fat. The 
equation determined by linear regression was 0.481 × re-
sected fat volume (mL) + 2.456, which was similar to a re-
cent report [24]. In that report, the mean Hertel change was 
A
B Fig. 4. Preoperative and postoperative pho-tographs and computed tomography (CT) 
scans in a 70-year-old female patient with 
compressive optic neuropathy, proptosis, 
restrictive myopathy, and congestion due to 
Graves’ orbitopathy, who underwent orbital 
fat and posterior two-wall decompression. 
(A) Preoperative photographs and CT scans. 
Red dotted line indicates the outline of fat 
removal. (B) Postoperative photographs and 
CT scans at 6 months after surgery. Conges-
tive symptoms and signs including chemosis, 
conjunctival injection, caruncular swelling, 
and lid erythema and swelling all resolved 
after surgery. Compressive optic neuropathy 
was also completely resolved.
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4.1 mm with a mean of 4.4 mL fat resection in 44 orbits 
from 22 patients. However, the ratio of average Hertel 
change to resected orbital fat volume was approximately 1 
in our cases, similar to the report by Liao and Huang [24], 
indicating a discrepancy between the linear regression re-
sult and the averages. This discrepant result is believed to 
be due to either a resistance to decompression due to dif-
ferent levels of tissue fibrosis among the patients or inclusion 
of pre-equatorial fat in the linear regression formula, 
which could not significantly reduce proptosis.
To reduce the incidence of postoperative diplopia, sever-
al surgical techniques including balanced orbital decom-
Table 2. Comparison of Postop results among groups
Clinical features Group 1 (n = 17 / 29 eye)
Group 2 
(n = 10 / 15 eye)
Group 3 
(n = 22 / 36 eye)
Group 4 
(n = 6 / 10 eye) Total p-value
Preop-Exo (mm)    20.1 ± 1.7       19.8 ± 0.9   21.3 ± 3.6 19.5 ± 2.5 20.6 ± 2.8 0.04
Postop-Exo* (mm)    16.3 ± 1.3       15.6 ± 1.2    16.2 ± 2.9 16.1 ± 2.0 16.1 ± 2.3 0.832
Difference-Exo†       3.8 ± 1.0         4.0 ± 1.1     5.1 ± 2.1    3.4 ± 1.2   4.3 ± 1.7 0.002
Fat (mL) 3.9 ± 1.0 (2.5-6) 2.0 ± 1.4 (1-2) 2.3 ± 1.1 (1-3.5) NA   2.1 ± 0.9 <0.001
Myopathy 
   Preop score 3 eye (%)       0 (0)          0 (0)       2 (5)      5 (50)     7 (7)
   Postop score 3 eye (%)       1 (3)          1 (6)         8 (22)      5 (50)    15 (16)
Group 1, fat removal only; Group 2, one-wall decompression + fat removal; Group 3, two-wall decompression + fat removal; Group 4, 
two-wall decompression with minimal fat removal (<1 mL).
ANOVA (p < 0.05).
Preop = preoperative; Postop = postoperative; Exo = exophthalmos; NA = not applicable.   
*Postop-Exo was evaluated six months after surgery; †Difference between Preop and Postop difference of Exo. 
Table 1. Preoperative demographic and clinical characteristics according to decompression type 
Clinical features Group 1 Group 2 Group 3 Group 4 Total
Patients (eyes) 17 (29) 10 (15) 22 (36)   6 (10)  55 (90)
Age (yr)   31.7 (19-51)   40.6 (26-58) 43.81 (21-77)   54.1 (46-70)     39.8 (19-70)
Gender M / F (%)       12 / 17 (70.5)        7 / 10 (70)     12 / 22 (54)         3 / 6 (50)      34 / 53 (64)
Myopathy*
   Score 3   2 / 17   1 / 10  4 / 22             4 / 6 11 / 55
   Score ≤2 15 / 17   9 / 10 18 / 22             2 / 6 44 / 55
Exo (mm)†         20.1 ± 1.7 19.8 ± 0.9         21.3 ± 3.6        19.5 ± 2.5         20.6 ± 2.8
ON (eyes %)   0 / 29   0 / 15           9 / 36 (25)       5 / 10 (50)      14 / 90 (15)
Duration of GD (mon)   51.13 (15-182)   67.34 (12-196)  25.13 (2-180)       34.80 (7-78)        35.23 (2-196)
Duration of GO (mon) 27.86 (12-62)   44.27 (10-112)  24.50 (2-180)       15.09 (4-35)        29.76 (2-180)
Smoker (%)             37.5             25             53.3             33.3              43
TSHR Ab
   Abnormal %             80             71.4             71.4            66.7              75
   Level          7.72 ± 9.58         4.01 ± 2.87         2.96 ± 1.80        6.42 ± 7.00 4.98 ± 5.58
   TSI-positive (%)             57.1             75            100             50             76.2
   Steroid pulse (%)              25           100
Exo = exophthalmos; ON = optic neuropathy; GD = Graves’ disease; GO = Graves’ orbitopathy; TSHR = thyroid stimulating hormone 
receptor; TSI = thyroid stimulation antibody.
*Myopathy score: 3 = diplopia or strabismus at primary gaze in any eye; 2 = diplopia within 30° in the binocular single vision test with 
significant limitation of movement in a Hess screen but orthophoria at primary gaze; †ANOVA (SPSS 18.0).
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pression [7,10], deep lateral wall decompression [33,34], 
prevention of the anterior periorbita [35], and intraconal fat 
removal [29,30,36] have been reported. However, there is 
no surgical standard to date. Induced diplopia after orbital 
decompression has been reported to be present in up to 
64% of patients [6]. Nunery et al. [37] reported that seven 
of 14 (50%) Nunery type II patients without preoperative 
primary-position diplopia had primary diplopia after orbit-
al inferomedial two-wall decompression. In our study, sev-
en patients had preoperative primary diplopia. Diplopia 
was aggravated postoperatively in eight patients (14.5%), 
and six of the eight patients were included in group 3, one 
in group 1, and one in group 2. All 15 patients with a post-
operative myopathy score of 3 had preoperative diplopia 
within 30 degrees of the central field and significant re-
striction of motility. 
Fat decompression may take more time than bone only 
decompression with regard to bleeding control and mini-
mization of damage to structures around muscles. Howev-
er, fat decompression has many advantages over other de-
compression types including preservation of the orbital 
walls and thus a lower incidence of surgically-induced dip-
lopia. Since fat decompression is not associated with bone 
removal, the potential for side effects, such as infraorbital 
nerve hypoesthesia, cerebrospinal fluid leak, and diplopia, 
are at least theoretically minimized [24,31]. Garrity [38] re-
ported that the diplopia seen in association with fat decom-
pression seemed to be different from the diplopia associated 
with bony decompression in that the disrupted intermuscular 
septa might cause more extensive restriction and be more 
difficult to repair than that seen with bony decompressions. 
Until approximately postoperative 1 to 3 months, pa-
tients in the present study complained of diplopia, which 
might be associated with a transient hypoglobus caused by 
massive removal of the inferior half of the orbital fat tis-
sues and the bleeding or edema around muscles related to 
the disruption of intermuscular septa. However, all patients 
showed significant improvement of diplopia and ocular 
motility within six months. There was only one patient in 
the fat-only removal group, a 65-year-old male who was a 
heavy smoker, who developed increased limitation of mo-
tion after the operation, as assessed by HESS, and in-
creased diplopia using BSV. He had a history of chronic 
maxillary and ethmoid sinusitis, which was still present in 
preoperative CT scan, although he underwent endoscopic 
sinus surgery before decompression. In preoperative evalu-
ation, right medial rectus muscle enlargement and sponta-
neous break of the right ethmoid bone were observed on 
CT scan. We performed fat decompression, with 6.5 mL 
taken from the right orbit and 6 mL taken from the left or-
bit, and a break in the posterior ethmoid was found intra-
operatively. Exophthalmos decreased from 23 mm OD, 22 
mm OS to 16 mm OD, 15 mm OS, and clinical activity 
score decreased from 6 to 1 postoperatively. A previous 
study reported that chronic sinusitis can worsen GO status 
[36]. Worsening of diplopia after fat decompression in this 
case might have been related to sinusitis or spontaneous 
bone decompression due to muscle enlargement. 
Additional lateral orbital wall removal was not necessary 
in any patients included in this study. We assume the rea-
son was that the amount of bone removal could be de-
creased after maximal orbital fat removal, or the clinical 
characteristics of GO either in Asian patients or just in pa-
tients included in the study were not severe enough to re-
quire three-wall decompression. The mean preoperative 
exophthalmos (±SD) was 20.6 ± 2.8 mm. Asian GO pa-
tients tend to demonstrate less severe proptosis or myopa-
thy than Caucasians [39] and thus may require less aggres-
sive wall decompression. Sasim et al. [40] reported that an 
approximately 5.6 mm reduction of proptosis was achieved 
by medial, f loor, and lateral bony wall decompression. 
However, the conservative bone expansion and intraconal 
fat removal using suction cutting only produced a mean of 
2.4 mm of proptosis reduction [41], suggesting that more 
aggressive removal of bones could produce further reduc-
tion of proptosis. 
A study recently reported that the long-term effect of 
unilateral orbital fat decompression for the reduction of 
proptosis may be weak, leading to regression [42], whereas 
wall decompression has characteristics largely opposite to 
those of fat decompression. In one case of a 45-year-old fe-
male, proptosis slightly progressed six months postopera-
tively. Her preoperative exophthalmos was measured as 20 
mm in both eyes, preoperative clinical activity score was 
zero, and the duration of GO was 30 months. The patient 
underwent orbital one-wall compression with fat removal 
in both eyes for cosmetically disfiguring proptosis. After 
six months of surgery, exophthalmos was 16.5 mm in both 
eyes without any signs of inflammation. However, the pa-
tient complained of regression of proptosis, with exoph-
thalmos measured as 18 mm at eight months after surgery 
in both eyes. However, no sign of orbital inflammation was 
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found, and thyroid hormone levels were within normal 
range. Two years postoperatively, exophthalmos stabilized 
as 17 mm in both eyes. Other than this case, there were no 
cases of proptosis regression observed in the present study; 
however, we could not compare results with patients who 
underwent surgery with no adjustment due to the retro-
spective nature of this study. further long-term follow-up 
study might be necessary to verify this phenomenon. 
In conclusion, maximal amounts of extraconal and in-
traconal fat excision with conservative removal of deep 
posterior intraconal fat, combined with traditional one- or 
two-posterior bony wall decompression based on intraop-
erative assessment of proptosis reduction can be an effec-
tive and safe surgical method.
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